Humana Lowered to Sell at Citigroup Inc. (HUM)
Humana (NYSE:HUM) was downgraded by analysts at Citigroup Inc. from a “neutral” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. They currently have a $95.00 price objective on the stock. Citigroup Inc.’s price objective would indicate a potential downside of 13.88% from the company’s current price. The analysts noted that the move was a valuation call.
HUM has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note on Thursday, February 6th. They now have a $100.00 price target on the stock. Separately, analysts at Jefferies Group cut their price target on shares of Humana from $115.00 to $111.00 in a research note on Thursday, February 6th. Finally, analysts at Barclays downgraded shares of Humana from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, January 8th. They now have a $109.00 price target on the stock. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $101.12.
Shares of Humana (NYSE:HUM) traded up 0.61% on Wednesday, hitting $110.98. 609,058 shares of the company’s stock traded hands. Humana has a 52-week low of $65.88 and a 52-week high of $114.76. The stock’s 50-day moving average is $98.78 and its 200-day moving average is $97.40. The company has a market cap of $17.095 billion and a P/E ratio of 14.27.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 5th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.95 by $1.14. The company had revenue of $10.20 billion for the quarter, compared to the consensus estimate of $10.23 billion. During the same quarter in the prior year, the company posted $1.19 earnings per share. The company’s quarterly revenue was up 6.6% on a year-over-year basis. On average, analysts predict that Humana will post $7.76 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, April 25th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Thursday, March 27th.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.